-
COVID-19 vaccines to enter late-stage trial by end of July: US’s top infectious diseases expert
expresspharma
July 03, 2020
The news comes as Moderna, which is at the forefront of the country’s vaccine development efforts, reiterated earlier in the day that a late-stage trial with 30,000 volunteers would begin this month.
-
Inovio’s COVID-19 vaccine candidate shows promise in small early-stage trial
expresspharma
July 02, 2020
The vaccine induced immune responses in 34 of the 36 healthy volunteers aged 18 to 50 years, Inovio said.
-
Swabs Designed by Harvard Wyss Institute Enter Human Trials for COVID-19
americanpharmaceuticalreview
May 04, 2020
Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab.
-
Adopting new guidelines could get medicines from CID trials to patients faster
europeanpharmaceuticalreview
January 07, 2020
The ECMC has published guidelines for Complex Innovative Design trails which could improve the conduct, quality and acceptability of oncology studies, enabling patients to get access to new medications more quickly.
-
Kadimastem Announces Results of Cohort A of ALS Trial
americanpharmaceuticalreview
September 26, 2019
Kadimastem announced promising interim results of cohort A of its Phase 1/2a clinical trial for the treatment of patients with Amyotrophic Lateral Sclerosis (ALS).
-
PhaseBio Announces Completion of Phase 2a Trial of PB2452
americanpharmaceuticalreview
September 26, 2019
PhaseBio Pharmaceuticals announced the completion of its Phase 2a clinical trial of PB2452. Full data from the trial are planned to be presented at an upcoming medical congress.
-
Cosentyx® (secukinumab) meets clinical trial endpoints
europeanpharmaceuticalreview
September 19, 2019
Cosentyx®, a treatment for an inflammatory disease has met its primary endpoints in patients during a Phase III trial.
-
Purdue reported to reach tentative agreement over opioid trial
europeanpharmaceuticalreview
September 16, 2019
A settlement has purportedly been agreed between Purdue Pharma and 23 US states to resolve the opioid crisis case against the company.
-
Lilly's Pain Clinical Trial Protocol Selected for FDA Trial Designs Pilot Meeting Program
americanpharmaceuticalreview
September 09, 2019
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) has accepted its application to enter the Complex Innovative Trial Designs (CID) Pilot Meeting Program...
-
Korean pharma company alleged to have conducted trials on employees
europeanpharmaceuticalreview
September 09, 2019
Ahngook Pharmaceuticals reportedly held clinical trials on its employees without their consent, leading to the arrest of the company president.